Cancer Immunotherapy Drug Discovery Outsourcing Market Forecast 2026–2035 with Industry Insights
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Estimated Market Size Of The Cancer Immunotherapy Drug Discovery Outsourcing Market During 2026–2030?
The cancer immunotherapy drug discovery outsourcing market has witnessed significant growth in recent years. This market is set to expand from $1.66 billion in 2025 to $1.84 billion in 2026, advancing at a compound annual growth rate (CAGR) of 10.9%. The historical growth for this period can be attributed to rising global cancer prevalence, increasing r&d costs for immunotherapy drugs, limited in-house discovery capabilities, growth in biologics and monoclonal antibody pipelines, and the expansion of cro infrastructure.
The cancer immunotherapy drug discovery outsourcing sector is anticipated to experience substantial expansion in the coming years. Its valuation is projected to reach $2.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.4%. This projected growth stems from factors such as a heightened need for precision immuno-oncology treatments, an increase in biotech startup creations, the increasing intricacy of immunotherapy approaches, the urgency to reduce drug development timeframes, and a surge in funding for outsourced discovery solutions. Key developments expected during this period involve an uptick in outsourcing for early-stage immunotherapy research, a greater need for specialized CRO knowledge, the enlargement of cell-based and immune assay offerings, enhanced partnerships between pharmaceutical and biotechnology companies, and the expedited creation of advanced immunotherapies.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15528&type=smp
Which Major Factors Are Driving The Expansion Of The Cancer Immunotherapy Drug Discovery Outsourcing Market?
The considerable expenditure associated with research and development is projected to boost the expansion of the cancer immunotherapy drug discovery outsourcing market in the future. These R&D expenses signify the significant capital needed for scientific knowledge, sophisticated lab setups, intricate technologies, and speculative innovation procedures. The escalation in scientific complexity and the demand for highly specialized skills continuously drive up R&D costs. The cancer immunotherapy drug discovery outsourcing market assists pharmaceutical and biotechnology firms by providing economical entry to advanced research facilities through contract research organizations (CROs). For instance in August 2025 accroding to the The Office for National Statistics (ONS) a UK-based Statistics Authority in 2023, expenditure on research and development (R&D) performed in the UK amounted to $95.2 billion, an increase of $3.93 billion in current prices since 2022. Consequently, the substantial expense of internal research and development is fueling the growth of the cancer immunotherapy drug discovery outsourcing market.
Cancer Immunotherapy Drug Discovery Outsourcing Market Driver: The Rise In Cancer Incidence Driving The Growth Of The Market Due To Increased Demand For Targeted Therapies
How Are The Various Segments Of The Cancer Immunotherapy Drug Discovery Outsourcing Market Categorized?
The cancer immunotherapy drug discovery outsourcing market covered in this report is segmented –
1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types
2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-Based Assays
3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas
Subsegments:
1) By Monoclonal Antibodies: Checkpoint Inhibitors, Therapeutic Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)
2) By Immunomodulators: Cytokines, Immune Checkpoint Modulators, Toll-Like Receptor Agonists, Immune Adjuvants
3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies, Cancer Vaccines, Viral Vectors For Immunotherapy
4) By Other Drug Types: Adoptive Cell Therapy, Immune Cell Modulators, Small Molecule Immune Modulators, Gene Editing And Immunotherapy
What Trends Are Affecting The Expansion Of The Cancer Immunotherapy Drug Discovery Outsourcing Market?
Leading companies in the cancer immunotherapy drug discovery outsourcing market are adopting strategic partnerships to accelerate the development of novel therapies. These collaborations significantly propel the growth of the cancer immunotherapy drug discovery outsourcing market by providing access to advanced technologies, specialized expertise, and integrated services, thereby reducing development timelines and improving the efficiency of bringing innovative cancer immunotherapies to the clinic. For instance, in September 2025, Charles River Laboratories, a US-based contract research organization, partnered with the Parker Institute for Cancer Immunotherapy, a US-based non-profit cancer research institute, to accelerate the development of novel cancer therapies. This collaboration focuses on enhancing preclinical testing and manufacturing capabilities for cutting-edge cell and gene therapies. By combining Charles River’s expertise in contract research with the Parker Institute’s immunotherapy programs, the partnership aims to deliver innovative cancer treatments to patients more efficiently.
Which Major Firms Influence Developments In The Cancer Immunotherapy Drug Discovery Outsourcing Market?
Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Oncodesign Services, Reaction Biology Corporation
Read the full cancer immunotherapy drug discovery outsourcing market report here:
Which Region Currently Holds The Largest Share Of The Cancer Immunotherapy Drug Discovery Outsourcing Market?
North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cancer Immunotherapy Drug Discovery Outsourcing Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15528&type=smp
Browse Through More Reports Similar to the Global Cancer Immunotherapy Drug Discovery Outsourcing Market 2026, By The Business Research Company
Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2026
Advanced Therapeutics Pharmaceutical Outsourcing Market Report 2026
Biologics Outsourcing Market Report 2026
https://www.thebusinessresearchcompany.com/report/biologics-outsourcing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
